2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Hepatitis C (HCV): new trials by email Literature Review of Hepatitis C (HCV) trials Research Report on Hepatitis C (HCV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin - Chronic Hepatitis C, Hepatitis C (HCV) | Phase 3 | Completed | AbbVie | 25 | 2015-06-01 | 2017-10-03 |
| Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases Naderin, Standard Therapy - Malignant Neoplasms, Tuberculosis (TB) | Phase 2 / Phase 3 | Completed | MIPO Clinic | 75 | 2013-05-15 | 2026-06-30 |
Hepatitis C (2) · Hepatitis C, Chronic (1) · Neoplasms (1) · Neutropenia (1) · Tuberculosis (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Digestive System Diseases (2) · Flaviviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · RNA Virus Infections (2) · Virus Diseases (2) · Actinomycetales Infections (1) · Agranulocytosis (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Chronic Disease (1)
Ribavirin (1) · Standard of Care (1) · dasabuvir (1) · ombitasvir (1) · sodium nucleinate (1)
AbbVie (1) · MIPO Clinic (1)
Emily Dumas, PhD (1)